Holen Sie sich die Stockscreener-App
33.96
0.85%
-0.29
Handel nachbörslich:
33.96
Qiagen Nv Aktie (QGEN) Neueste Nachrichten
QIAGEN NV Hits Day Low of $33.82 Amid Price Pressure - Markets Mojo
Primer: QIAGEN NV (QIA GY)May 2026 - Smartkarma
QIAGEN NV : Jefferies maintains a Buy rating - marketscreener.com
How The Qiagen (QGEN) Investment Story Is Shifting As Analysts Rework Their Assumptions - Yahoo Finance
Qiagen Trims 2026 Outlook After Mixed Q1 and QuantiFERON Weakness - TipRanks
Qiagen (NYSE:QGEN) Upgraded by Zacks Research to "Hold" Rating - MarketBeat
QGEN Stock Price, Quote & Chart | QIAGEN N.V. (NYSE:QGEN) - ChartMill
QIAGEN NV cuts FY outlook despite in-line prelim Q1 EPS - MSN
QIAGEN N.V. (QGEN.US) will release its earnings report after the market closes on May 6. - Moomoo
Lower QuantiFERON demand leads QIAGEN (NYSE: QGEN) to trim 2026 outlook - Stock Titan
A Quick Look at Today's Ratings for Qiagen NV(QGEN.US), With a Forecast Between $38 to $45 - Moomoo
MSN Money - MSN
Robert W. Baird Upgrades Qiagen (NYSE:QGEN) to Strong-Buy - MarketBeat
Morgan Stanley Maintains Qiagen NV(QGEN.US) With Hold Rating, Cuts Target Price to $39.69 - Moomoo
Qiagen Shares Plunge 10.7 Percent to Seven Year Low - HarianBasis.co
Pictet Asset Management Holding SA Reduces Holdings in Qiagen N.V. $QGEN - MarketBeat
Baird upgrades Qiagen NV (QGEN) - MSN
Qiagen Is Maintained at Overweight by JP Morgan - Moomoo
Barclays downgrades Qiagen NV (QGEN) - MSN
QGEN Maintained by JP Morgan -- Price Target Lowered to $45 - GuruFocus
QGEN Maintained by Citigroup -- Price Target Lowered to $38.00 - GuruFocus
JPMorgan Chase & Co. Has Lowered Expectations for Qiagen (NYSE:QGEN) Stock Price - MarketBeat
Citigroup Lowers Qiagen (NYSE:QGEN) Price Target to $38.00 - MarketBeat
QGEN Maintained by Barclays -- Price Target Lowered to $38.00 - GuruFocus
Global Metagenomics Sequencing Market to Register Stunning Growth at a CAGR of ~13% by 2034 | DelveInsight - GlobeNewswire Inc.
Citi Maintains Qiagen NV(QGEN.US) With Hold Rating, Cuts Target Price to $38 - Moomoo
QIAGEN NV Hits 52-Week Low at USD 33.82 Amidst Declining Performance - Markets Mojo
Morgan Stanley Cuts Price Target on QIAGEN to $40 From $51, Keeps Equalweight Rating - marketscreener.com
QGEN Upgraded by Baird -- Price Target Lowered to $43.00 - GuruFocus
Baird Upgrades QIAGEN to Outperform From Neutral, Cuts Price Target to $43 From $53 - marketscreener.com
Qiagen Sets Date for Publication of 2025 Annual Financial Report - The Globe and Mail
QIAGEN NV : DZ Bank gives a Buy rating - marketscreener.com
Qiagen (QGEN) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Qiagen (NYSE:QGEN) Sets New 12-Month LowShould You Sell? - MarketBeat
Qiagen N.V. (NYSE:QGEN) Receives Average Rating of "Hold" from Analysts - MarketBeat
Qiagen NV (QGEN) Q1 2026 Earnings Call Highlights: Navigating Mi - GuruFocus
Baird upgrades Qiagen stock rating on valuation after pullback By Investing.com - Investing.com India
Stifel Maintains Qiagen NV(QGEN.US) With Hold Rating, Maintains Target Price $50 - Moomoo
Baird upgrades Qiagen stock rating on valuation after pullback - Investing.com
QIAGEN NV : Barclays reiterates its Neutral rating - marketscreener.com
Baird Upgrades Qiagen NV (QGEN) to Outperform - StreetInsider
Is Qiagen NV (QGEN) a Bargain After 10.7% Drop? GF Value Says Un - GuruFocus
Qiagen NV (QGEN) Falls to 7-Year Low as MidEast Tensions Drag Q1 - Yahoo Finance
Qiagen N.V. Shareholders Are Encouraged to Reach Out to - GlobeNewswire
Earnings Call Summary | Qiagen NV(QGEN.US) Q1 2026 Earnings Conference - Moomoo
QIAGEN NV : Jefferies keeps its Buy rating - marketscreener.com
Qiagen NV (QGEN) PT Lowered to $38 at Barclays - StreetInsider
Qiagen (NYSE:QGEN) Sees Strong Trading VolumeShould You Buy? - MarketBeat
QIAGEN slides after cutting 2026 outlook, citing weaker QuantiFERON demand and cautious customer spending - Quiver Quantitative
German Shares Slip; Qiagen Tumbles on Outlook Downgrade - marketscreener.com
Qiagen N.V. 2026 Q1ResultsEarnings Call Presentation (NYSE:QGEN) 2026-04-28 - Seeking Alpha
Preliminary Q1 2026 Qiagen NV Earnings Call Transcript - GuruFocus
Qiagen: Weak Q1 and guidance cut unsettle the market - marketscreener.com
A Quick Look at Today's Ratings for Qiagen NV(QGEN.US), With a Forecast Between $44 to $50 - Moomoo
Barclays Maintains Qiagen NV(QGEN.US) With Hold Rating, Maintains Target Price $44 - Moomoo
Incyte's strong Q1 beat contrasts with QIAGEN outlook cut - MSN
Deutsche Bank Maintains Qiagen NV(QGEN.US) With Buy Rating - Moomoo
QIAGEN NV : Deutsche Bank remains its Buy rating - marketscreener.com
2.64%
0.61%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):